{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:42:42Z","timestamp":1791650562625,"version":"4.3.4"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,7]]},"DOI":"10.7759\/cureus.61871","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T09:10:20Z","timestamp":1717751420000},"source":"Crossref","is-referenced-by-count":2,"title":["Metastatic Urothelial Carcinoma With Sarcomatoid Subtype After Robot-Assisted Radical Cystectomy Successfully Treated With Pembrolizumab"],"prefix":"10.7759","author":[{"given":"Kazumasa","family":"Murase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Nakane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Iinuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Koie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01626-9","article-title":"Sarcomatoid variant urothelial carcinoma of the bladder: a systematic review and meta-analysis of the clinicopathological features and survival outcomes","volume":"20","author":"Gu L","year":"2020","unstructured":"Gu L, Ai Q, Cheng Q, et al.. Sarcomatoid variant urothelial carcinoma of the bladder: a systematic review and meta-analysis of the clinicopathological features and survival outcomes. Cancer Cell Int. 2020, 20:550. 10.1186\/s12935-020-01626-9","journal-title":"Cancer Cell Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613683","article-title":"Pembrolizumab as second-line therapy for advanced urothelial carcinoma","volume":"376","author":"Bellmunt J","year":"2017","unstructured":"Bellmunt J, de Wit R, Vaughn DJ, et al.. Pembrolizumab as second-line therapy for advanced urothelial carcinoma. N Engl J Med. 2017, 376:1015-26. 10.1056\/NEJMoa1613683","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-220030","article-title":"PD-L1 expression and CD8 positive lymphocytes in human neoplasms: a tissue microarray study on 11,838 tumor samples","volume":"36","author":"M\u00f6ller K","year":"2023","unstructured":"M\u00f6ller K, Kn\u00f6ll M, Bady E, et al.. PD-L1 expression and CD8 positive lymphocytes in human neoplasms: a tissue microarray study on 11,838 tumor samples. Cancer Biomark. 2023, 36:177-91. 10.3233\/CBM-220030","journal-title":"Cancer Biomark"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15510","article-title":"Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis","volume":"130","author":"Kobayashi M","year":"2022","unstructured":"Kobayashi M, Narita S, Matsui Y, et al.. Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis. BJU Int. 2022, 130:226-34. 10.1111\/bju.15510","journal-title":"BJU Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-021-02061-0","article-title":"Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis","volume":"27","author":"Yanagisawa T","year":"2022","unstructured":"Yanagisawa T, Mori K, Katayama S, et al.. Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis. Int J Clin Oncol. 2022, 27:59-71. 10.1007\/s10147-021-02061-0","journal-title":"Int J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/194988-metastatic-urothelial-carcinoma-with-sarcomatoid-subtype-after-robot-assisted-radical-cystectomy-successfully-treated-with-pembrolizumab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T09:10:23Z","timestamp":1717751423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/194988-metastatic-urothelial-carcinoma-with-sarcomatoid-subtype-after-robot-assisted-radical-cystectomy-successfully-treated-with-pembrolizumab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.61871","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,7]]}}}